Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy.

BMC cancer·2024

Same author

The predictability and patterns of vigilant behaviour.

Behavioural processes·2014

Same author

A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear.

Molecular psychiatry·2013

Same author

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Same author

Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario.

Current oncology (Toronto, Ont.)·2013

Same author

Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026

Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026

Same journal

Vulvar punch biopsy for evaluating vulvar dermatoses in primary care: Procedural guide.

Canadian family physician Medecin de famille canadien·2026

Same journal

Approach to sport-savvy contraceptive counselling for athletes.

Canadian family physician Medecin de famille canadien·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Multiple myeloma.

Canadian Family Physician Medecin De Famille Canadien

|January 29, 2011

Summary

This summary is machine-generated.

Multiple myeloma is a plasma cell cancer causing skeletal, kidney, and immune issues. Diagnosis involves detecting monoclonal proteins and bone marrow abnormalities, with treatment focusing on supportive care and tumor reduction.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Related Experiment Videos

Last Updated: Jun 4, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Area of Science:

Hematology
Oncology
Internal Medicine

Background:

Multiple myeloma arises from abnormal plasma cell proliferation.
This leads to monoclonal antibody production and characteristic clinical problems.

Purpose of the Study:

To outline the key features, diagnostic criteria, and management strategies for multiple myeloma.

Main Methods:

Review of clinical manifestations and diagnostic indicators.
Description of therapeutic approaches for managing complications and tumor burden.

Main Results:

Common complications include skeletal disease, hypercalcemia, bone marrow dysfunction, sepsis, and renal failure.
Diagnosis is supported by serum monoclonal gammopathy or urinary light chains, bone marrow plasmacytosis, hypogammaglobulinemia, and lytic bone lesions.

Conclusions:

Effective management involves addressing complications, utilizing radiotherapy for bone disease, and chemotherapy for tumor burden reduction.